433 results on '"MANSUETO, GIOVANNI"'
Search Results
102. Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center
103. Mental pain and pain-proneness in patients with migraine: results from the PAINMIG cohort-study
104. Metacognitive beliefs and childhood adversities: an overview of the literature
105. Role of rumination in the relationship between metacognition and shyness
106. Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
107. Childhood Adversity, Cortisol Levels, and Psychosis
108. The Role of Anxiety Sensitivity and Expectancy Manipulation on Panic-Like Response to the 35% CO2 Challenge in Healthy Subjects.
109. Metacognitive beliefs and childhood adversities: an overview of the literature.
110. Correction: Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
111. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer
112. Parasomnias and Childhood Adversity in an Adult Psychiatric Population
113. Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
114. The DSM-5 effect: psychological characteristics of new patients affected by Binge Eating Disorder following the criteria of the DSM-5 in a sample of severe obese patients
115. Cabazitaxel after Docetaxel in patients with metastatic, castration-resistant, prostate cancer (mCRPC): A prospective, observational study about toxicity profile and quality of life.
116. The Role of Metacognition in Pathological Gambling: A Mediation Model
117. [Erlotinib in the treatment of NSCLC: current and novel prospects from the ASCO 2006]
118. Tumor-related symptoms (TRS) assessment in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with gefitinib or erlotinib: Preliminary results of an observational study.
119. Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey.
120. Temozolomide (TMZ) maintenance in patients with primary brain cancer treated with postoperative TMZ plus radiotherapy (RT): A retrospective analysis.
121. The predictive value of clinical variables in patients affected with non-small-cell lung cancer (NSCLC) treated with pemetrexed (PEM) plus platinum-based regimen: A retrospective analysis.
122. First-line cisplatin-fractionated doublet for unfit patients with advanced/metastatic non-small cell lung cancer.
123. Palonosetron (PALO) plus 1-day versus 3-day dexamethasone (DEX) with or without aprepitant against delayed nausea (DN): Pooled analysis for 554 women receiving highly emetogenic chemotherapy (HEC).
124. Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center
125. Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy
126. ASCO 2006 Progressi nel trattamento con bevacizumab del carcinoma del colon-retto metastatico
127. Erloiinib Nel Trattamento del NSCLC: Attualità e Nuove Prospettive DALL'ASCO 2006
128. Nuove vie di trattamento del carcinoma del colon-retto: Dalla chemioterapia orale agli inibitori dell'angiogenesi
129. ECCO 2005 Progressi nella Prevenzione della Nausea e del Vomito da Chemioterapia
130. Docetaxel e Nuove Strategie di Trattamento del NSCLC
131. Verso La Guarigione Dei Tumori Solidi “Early-Stage”: Ruolo Del Docetaxel
132. Epoetina Alfa Nel Trattamento Dell'Anemia Secondaria a Chemioterapia
133. Bevacizumab in Associazione Con La Chemioterapia Nel Trattamento Dei Tumori Solidi: Novitá Dall'Asco 2005
134. The Combination of the Selective Cyclooxygenase-2 Inhibitor Celecoxib with Weekly Paclitaxel Is a Safe and Active Second-Line Therapy for Non-Small Cell Lung Cancer
135. Asco 2005: Progressi Con Oxaliplatino Nel Trattamento Dei Tumori Del Colon-Retto
136. ESMO 2004 Nausea e Vomito da Chemioterapia: Ottimizzazione del Trattamento
137. Esmo 2004 Studi Di Confronto Che Delineano le Opzioni Future Nel Trattamento Dei Tumori Solidi
138. Congresso AIOM 2004 Revisione Critica del Ruolo di Docetaxel nel Carcinoma Polmonare non Microcitoma
139. Congresso AIOM 2004 Endocrinoterapia e Gestione di Pazienti con Metastasi Ossee da Carcinoma Mammario
140. Convegno ESMO 2004 Ibandronato nel Trattamento Delle Metastasi Ossee
141. ASCO Annual Meeting 2004, New Orleans Capecitabina nel trattamento adiuvante del carcinoma del colon-retto: First … the evidence
142. ASCO Annual Meeting 2004, New Orleans Gemcitabina nel carcinoma mammario metastatico
143. ASCO Annual Meeting 2004, New Orleans Angiogenesi Tumorale ed Inibizione di VEGF: Implicazioni Cliniche
144. ASCO Annual Meeting 2004, New Orleans Opzioni Terapeutiche Nel Carcinoma Del Colon-Retto
145. Ibandronato: Keep Life in Motion
146. La Terapia Orale Con Capecitabina: Esperienze e Sviluppi Dell'istituto Tumori di Milano
147. La Terapia Endocrina Come Terapia Causale: Ruolo Degli Inibitori Dell'aromatasi nel Carcinoma Della Mammella
148. Second line treatment of antiangiogenic therapy with celecoxib and weekly paclitaxel for advanced non-small cell lung cancer (NSCLC)
149. Asco 2003 Cosa Sta Cambiando Nella Terapia Del Carcinoma Del Colon-Retto
150. Nuove prospettive nel trattamento del tumore del colon-retto avanzato
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.